Important: New Requirements for Applying to the HHS SBIR Omnibus Solicitation

NCI Cancer Grant Funding

HHS Re-issues 2013 Omnibus Solicitation to Implement Additional Provisions of the SBIR/STTR

Reauthorization Act of 2011
Original 2013 SBIR/STTR Omnibus Solicitations are now expired

All applicants to the National Cancer Institute (NCI) SBIR & STTR Programs must use the re-issued PHS 2013-2 Omnibus Grant Solicitations, PA-13-234 (SBIR) and PA-13-235 (STTR) for the upcoming August 5 and December 5 deadlines.

Funding is available to support small businesses working across a wide range of cancer-related research topic areas through the Small Business Innovation Research and Small Business Technology Transfer (SBIR & STTR) Omnibus Solicitation, an investigator-initiated grant funding opportunity. The next deadline to submit applications is August 5, 2013.

The original SBIR and STTR Omnibus Solicitations, PA-13-088 (SBIR) and PA-13-089 (STTR) are now expired.

  • Applicants will receive an error during submission if these expired funding opportunity announcements (FOAs) are used.
  • Please download and use the re-issued Omnibus Solicitation FOAs (PA-13-234, SBIR and PA-13-235, STTR) for all applications to the remaining due dates. This includes resubmissions (‘-A1s’).

The re-issued 2013 Omnibus Solicitation expands eligibility and impacts the application process, so please read the solicitations carefully. With this re-issue, the NIH SBIR/STTR programs implement the following provisions of the SBIR/STTR Reauthorization Act:

  • Small business concerns that are majority-owned by multiple venture capital operating companies (VCOCs), hedge funds and/or private equity firms are now eligible to apply to the NIH SBIR program and compete for up to 25% of NIH’s SBIR set-aside.
  • All applicants are required to register at the SBA Company Registry prior to application submission and attach proof of registration.

For further details, please see NIH Guide Notice NOT-OD-13-071 or check the NIH implementation plan website.

To view the official re-issued 2013 SBIR & STTR Omnibus Solicitations, please visit:

SBIR Program
PA-13-234, Re-issue PHS 2013-02 Omnibus Solicitation of the NIH, CDC, FDA and ACF for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44])
Receipt Dates: August 5, 2013; December 5, 2013

STTR Program
PA-13-235, Re-issue PHS 2013-02 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42])
Receipt Dates: August 5, 2013; December 5, 2013

How to Apply
For resources and tips for applying, please click here.

NCI encourages U.S. small businesses to submit investigator-initiated SBIR & STTR grant applications for any mission-aligned innovative technologies. To review descriptions of research topics of particular interest, please click here. For more information about this opportunity, please click here.

Please visit to learn more about the NCI SBIR & STTR Programs.


The SBIR & STTR Programs are NCI’s engine of innovation for developing and commercializing novel technologies and products to prevent, diagnose, and treat cancer. The SBIR & STTR Programs are government set-aside programs for domestic small businesses to engage in research and development that has the potential for commercialization and public benefit.

Sign up to receive updates about
SBIR & STTR funding opportunities at


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: